These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 33864846)

  • 21. Buprenorphine for chronic pain.
    Calderon R; Copenhaver D
    J Pain Palliat Care Pharmacother; 2013 Dec; 27(4):402-5. PubMed ID: 24245573
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implementation of a collaborative care management program with buprenorphine in primary care: a comparison between opioid-dependent patients and patients with chronic pain using opioids nonmedically.
    Suzuki J; Matthews ML; Brick D; Nguyen MT; Wasan AD; Jamison RN; Ellner AL; Tishler LW; Weiss RD
    J Opioid Manag; 2014; 10(3):159-68. PubMed ID: 24944066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic Pain Does Not Impact Baseline Circulating Cytokine Levels in Adults with Sickle Cell Disease.
    Karafin MS; Simpson P; Field JJ
    Acta Haematol; 2021; 144(1):111-116. PubMed ID: 32403100
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A preliminary study comparing methadone and buprenorphine in patients with chronic pain and coexistent opioid addiction.
    Neumann AM; Blondell RD; Jaanimägi U; Giambrone AK; Homish GG; Lozano JR; Kowalik U; Azadfard M
    J Addict Dis; 2013; 32(1):68-78. PubMed ID: 23480249
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Controlling the Swing of the Opioid Pendulum.
    Comerci G; Katzman J; Duhigg D
    N Engl J Med; 2018 Feb; 378(8):691-693. PubMed ID: 29466151
    [No Abstract]   [Full Text] [Related]  

  • 26. Patients with chronic pain.
    Salama-Hanna J; Chen G
    Med Clin North Am; 2013 Nov; 97(6):1201-15. PubMed ID: 24182727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retrospective analysis of 4 years of clinical experience with transdermal buprenorphine (Transtec) in post-traumatic pain.
    Correa-Illanes G; Roa RG; B Piñeros JL; Ferrer FT; Adriasola VR
    Pain Manag; 2014 May; 4(3):181-90. PubMed ID: 24835268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Buprenorphine for chronic pain treatment and elective orthopaedic surgery: a US national database analysis.
    Stone AB; Zhong H; Poeran J; Liu J; Cozowicz C; Illescas A; Memtsoudis SG
    Br J Anaesth; 2023 Mar; 130(3):e404-e406. PubMed ID: 36566125
    [No Abstract]   [Full Text] [Related]  

  • 29. Psychiatric and medical comorbidities, associated pain, and health care utilization of patients prescribed buprenorphine.
    Mark TL; Dilonardo J; Vandivort R; Miller K
    J Subst Abuse Treat; 2013; 44(5):481-7. PubMed ID: 23265445
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An observational study of buprenorphine treatment of the prescription opioid dependent pain patient.
    Streltzer J; Davidson R; Goebert D
    Am J Addict; 2015 Jun; 24(4):357-61. PubMed ID: 25675861
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sickle cell anemia and pain: will data prevail over beliefs?
    Payne R
    Ann Emerg Med; 2009 May; 53(5):596-7. PubMed ID: 19380037
    [No Abstract]   [Full Text] [Related]  

  • 32. WITHDRAWN: Pain management for sickle cell disease in children and adults.
    Dunlop R; Bennett KC
    Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD003350. PubMed ID: 24711059
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness and tolerability of transdermal buprenorphine patches: a multicenter, prospective, open-label study in Asian patients with moderate to severe chronic musculoskeletal pain.
    Yoon DH; Bin SI; Chan SK; Chung CK; In Y; Kim H; Lichauco JJ; Mok CC; Moon YW; Ng TK; Penserga EG; Shin DA; You D; Moon H
    BMC Musculoskelet Disord; 2017 Aug; 18(1):337. PubMed ID: 28778219
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimizing Interdisciplinary Virtual Pain Care and Buprenorphine Initiation During COVID-19: A Quality Improvement Study.
    Edmond SN; Currie S; Gehrke A; Falker CG; Sung M; Abelleira A; Edens EL; Becker WC
    Pain Med; 2022 May; 23(6):1043-1046. PubMed ID: 34940877
    [No Abstract]   [Full Text] [Related]  

  • 35. When opioids fail in chronic pain management: the role for buprenorphine and hospitalization.
    Berland DW; Malinoff HL; Weiner MA; Przybylski R
    Am J Ther; 2013; 20(4):316-21. PubMed ID: 23584313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New and emerging treatments for vaso-occlusive pain in sickle cell disease.
    Dampier C
    Expert Rev Hematol; 2019 Oct; 12(10):857-872. PubMed ID: 31364883
    [No Abstract]   [Full Text] [Related]  

  • 37. Buprenorphine use for pain and suicidal ideation in severely suicidal patients.
    Gibbs HM; Price D; Delgado PL; Clothier JL; Cáceda R
    Int J Psychiatry Med; 2020 Nov; 55(6):387-396. PubMed ID: 32216493
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Complex Case of Kratom Dependence, Depression, and Chronic Pain in Opioid Use Disorder: Effects of Buprenorphine in Clinical Management.
    Bowe A; Kerr PL
    J Psychoactive Drugs; 2020; 52(5):447-452. PubMed ID: 32546067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic potential of β-lactam ceftriaxone for chronic pain in sickle cell disease.
    He Y; Guo X; Wang ZJ
    Haematologica; 2023 Feb; 108(2):633-637. PubMed ID: 36300778
    [No Abstract]   [Full Text] [Related]  

  • 40. Sublingual Buprenorphine for Pediatric Cancer Pain: A Case Report and Review of the Literature.
    Quirk K; Wright J; Marks A; Smith MA
    J Pain Symptom Manage; 2020 Nov; 60(5):1055-1058. PubMed ID: 32739561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.